MiNK Therapeutics Email Formats

Biotechnology Research • Lexington, Massachusetts, United States • 21-50 Employees

MiNK Therapeutics Email Formats

MiNK Therapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@minktherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@minktherapeutics.com	100%

Key Contacts at MiNK Therapeutics

Robert Stein

Senior R&D Advisor & Founder

Thiago Favano

Senior Director, Program Operations

Marco Purbhoo

Director, Translational Research

Barbara Ramos

Executive Director, Program Management

Company overview

Headquarters	3 Forbes Rd, Lexington, Massachusetts 02421, US
Phone number	+12129948250
Website	minktherapeutics.com
NAICS	541714
Keywords	Adoptive Cell Therapy, Living Drugs, T Cell Receptors (Tcrs)
Founded	2017
Employees	21-50
Socials

About MiNK Therapeutics

We are a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells are a distinct T cell population that combine durable memory responses with the rapid cytolytic features of natural killer (NK) cells. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells and suppress Graft versus Host Disease (GvHD). Our proprietary platform is designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. As such, we believe that our approach represents a highly versatile application for therapeutic development in cancer and immune diseases. We have leveraged our platform and manufacturing capabilities to develop a wholly owned pipeline for both native and engineered iNKT cells.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

MiNK Therapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore MiNK Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-13	14	$5,800,000
2025-07-02	9	N/A

Funding Insights

$5,800,000

Total funding amount

Number of funding rounds

MiNK Therapeutics Tech Stack

Discover the technologies and tools that power MiNK Therapeutics's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Dropbox

Digital asset management

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Animate.css

UI frameworks

Elementor

Page builders

Cloudflare

CDN

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Frequently asked questions

MiNK Therapeutics is located in Lexington, Massachusetts, US.

You can reach MiNK Therapeutics at +12129948250.

MiNK Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

MiNK Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

MiNK Therapeutics has raised a total of $5,800,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at MiNK Therapeutics

Robert Stein

Senior R&D Advisor & Founder

Thiago Favano

Senior Director, Program Operations

Marco Purbhoo

Director, Translational Research

Barbara Ramos

Executive Director, Program Management

4.8

40,000 users